If Effective, Experimental Hookworm Vaccine Could Help Lower Morbidity, Mortality From Iron-Deficiency Anemia

Health Affairs Blog: Vaccinating Against Iron-Deficiency Anemia: A New Technology For Maternal And Child Health
Peter Hotez, president of the Sabin Vaccine Institute and dean of the National School of Tropical Medicine at Baylor College of Medicine, and Remko van Leeuwen, HOOKVAC project director at the Amsterdam Institute for Global Health and Development, discuss morbidity and mortality related to iron-deficiency anemia, how hookworm infection contributes to the condition, and the testing of an experimental hookworm vaccine (2/19).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.